stockmarketnews.online EDGAR snapshot
The Filings Docket Corporate filings, explained: what large U.S. companies filed with the SEC, and what it means.

In re: AbbVie Inc. · CIK 0001551152

When will AbbVie Inc. file its next 10-Q?

ABBV · NYSE
Snapshot

AbbVie Inc. is expected to file its next quarterly report (Form 10-Q), for the period ending about Sept. 30, 2026, between Nov. 2, 2026 and Nov. 9, 2026, based on its last 8 10-Q filings. The SEC deadline for a large accelerated filer is Nov. 9, 2026.

How the next-report window is calculated

AbbVie Inc.'s most recent periodic report on file is a Form 10-Q for the period ended June 30, 2026, filed Aug. 3, 2026. Its fiscal year ends around Dec. 31, so the next period should close about Sept. 30, 2026, and that report is a Form 10-Q.

SEC rules give a large accelerated filer 40 days after period end to file a 10-Q, which lands on Nov. 9, 2026 after moving off weekends and federal holidays. Over its last 8 10-Qs, AbbVie Inc. filed between 33 and 39 days after period end (median 35 days), which gives the expected window above. Period ends are estimated from the company's own calendar and may shift by a few days in 52/53-week fiscal years.

AbbVie Inc.: days from period end to 10-Q/10-K filing 10-Q for period ended 2024-09-30: filed 35 days later; 10-K for period ended 2024-12-31: filed 45 days later; 10-Q for period ended 2025-03-31: filed 39 days later; 10-Q for period ended 2025-06-30: filed 35 days later; 10-Q for period ended 2025-09-30: filed 35 days later; 10-K for period ended 2025-12-31: filed 51 days later; 10-Q for period ended 2026-03-31: filed 38 days later; 10-Q for period ended 2026-06-30: filed 34 days later. 10-Q due: 40d 10-K due: 60d 10-Q · Sept. 30 24 35d 10-K · Dec. 31 24 45d 10-Q · March 31 25 39d 10-Q · June 30 25 35d 10-Q · Sept. 30 25 35d 10-K · Dec. 31 25 51d 10-Q · March 31 26 38d 10-Q · June 30 26 34d days from period end to filing date →

Recent filings by AbbVie Inc.

Most recent 25 filings excluding insider Forms 3/4/5/144 · SEC EDGAR, retrieved Oct. 16, 2026
FiledFormWhat it isDocument
8-K Executive or board change, or executive pay arrangement Open 8-K filed 2026-10-15 · Index 0001104659-26-116227
8-K Released earnings or financial results Open 8-K filed 2026-10-05 · Index 0001551152-26-000030
8-K Information shared under Regulation FD Open 8-K filed 2026-09-03 · Index 0001104659-26-104940
8-K Other events the company chose to report Open 8-K filed 2026-08-18 · Index 0001104659-26-098367
8-K Other events the company chose to report Open 8-K filed 2026-08-05 · Index 0001104659-26-091269
10-Q Quarterly report with unaudited financial statements for the period ended June 30, 2026 Open 10-Q filed 2026-08-03 · Index 0001551152-26-000026
8-K Released earnings or financial results Open 8-K filed 2026-07-31 · Index 0001551152-26-000023
8-K Released earnings or financial results Open 8-K filed 2026-07-06 · Index 0001551152-26-000021
11-K Annual report of an employee stock purchase or savings plan Open 11-K filed 2026-06-24 · Index 0001104659-26-077366
8-K Information shared under Regulation FD Open 8-K filed 2026-06-22 · Index 0001104659-26-076067
SD Specialized disclosure (conflict minerals / resource payments) Open SD filed 2026-06-01 · Index 0001104659-26-069017
8-K Reported shareholder vote results Open 8-K filed 2026-05-12 · Index 0001104659-26-059484
10-Q Quarterly report with unaudited financial statements for the period ended March 31, 2026 Open 10-Q filed 2026-05-08 · Index 0001551152-26-000017
13G Ownership above 5% by a passive or institutional investor Open SCHEDULE 13G filed 2026-04-29 · Index 0002100119-26-000126
8-K Released earnings or financial results Open 8-K filed 2026-04-29 · Index 0001551152-26-000013
8-K Released earnings or financial results Open 8-K filed 2026-04-03 · Index 0001551152-26-000011
13G/A Amendment to a passive-ownership (13G) report Open SCHEDULE 13G/A filed 2026-03-26 · Index 0000102909-26-000503
ARS Annual report delivered to shareholders Open ARS filed 2026-03-23 · Index 0001104659-26-033397
DEFA14A Additional proxy soliciting materials Open DEFA14A filed 2026-03-23 · Index 0001104659-26-033391
DEF 14A Definitive proxy statement for a shareholder meeting Open DEF 14A filed 2026-03-23 · Index 0001104659-26-033387
PRE 14A Preliminary proxy statement Open PRE 14A filed 2026-03-09 · Index 0001104659-26-025260
8-K Other events the company chose to report Open 8-K filed 2026-03-04 · Index 0001104659-26-023534
8-K Other events the company chose to report Open 8-K filed 2026-02-26 · Index 0001104659-26-020643
10-K Annual report with audited financial statements for the period ended Dec. 31, 2025 Open 10-K filed 2026-02-20 · Index 0001551152-26-000008
8-K Released earnings or financial results Open 8-K filed 2026-02-04 · Index 0001551152-26-000004

What AbbVie Inc.'s 8-Ks were about in the past year

AbbVie Inc. filed 16 Form 8-K current reports between Oct. 17, 2025 and Oct. 16, 2026. Each report lists the item numbers it covers; the counts below show how often each item appeared.

ItemMeaningTimes
9.01Financial Statements and Exhibits14
2.02Results of Operations and Financial Condition8
8.01Other Events4
7.01Regulation FD Disclosure2
5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers1
5.07Submission of Matters to a Vote of Security Holders1

See what each 8-K item means.